Pages that link to "Q35669794"
Jump to navigation
Jump to search
The following pages link to Hepatic steatosis in obese patients: clinical aspects and prognostic significance. (Q35669794):
Displaying 50 items.
- Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis (Q24243149) (← links)
- Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis (Q24247315) (← links)
- Complex role of autophagy in regulation of hepatic lipid and lipoprotein metabolism (Q26747101) (← links)
- Obesity, nutrition, and liver disease in children (Q27002523) (← links)
- A Review of the Toxicologic Implications of Obesity (Q28082947) (← links)
- Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice (Q28488272) (← links)
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms (Q29615455) (← links)
- Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? (Q30486634) (← links)
- Role of iron in hepatic fibrosis: one piece in the puzzle (Q33344424) (← links)
- Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers (Q33370028) (← links)
- MR spectroscopy of the liver: principles and clinical applications. (Q33517208) (← links)
- Hepatitis and liver disease knowledge and preventive practices among health workers in Mexico: a cross-sectional study (Q33579221) (← links)
- Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents (Q33591710) (← links)
- Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signaling (Q33746400) (← links)
- Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial (Q33777242) (← links)
- Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death (Q33840334) (← links)
- Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease (Q33869030) (← links)
- Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency (Q34284698) (← links)
- Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats (Q34567427) (← links)
- New clinical score to diagnose nonalcoholic steatohepatitis in obese patients (Q34662500) (← links)
- Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study (Q34690842) (← links)
- Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice (Q34761076) (← links)
- Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease (Q35055531) (← links)
- Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease (Q35200808) (← links)
- Hepatitis infection in the treatment of opioid dependence and abuse. (Q35389163) (← links)
- The role of metformin in the management of NAFLD (Q35614956) (← links)
- Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals. (Q35668934) (← links)
- Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. (Q35711956) (← links)
- Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice (Q35775685) (← links)
- Association between serum alanine aminotransferase level and obesity indices in Korean adolescents (Q35782502) (← links)
- Stearoyl-CoA desaturase as a new drug target for obesity treatment. (Q36100781) (← links)
- Non alcoholic fatty liver disease: a clinical approach and review (Q36475998) (← links)
- Lipotoxicity: effects of dietary saturated and transfatty acids (Q36610458) (← links)
- Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients (Q36846905) (← links)
- Sleep Dysfunction and Gastrointestinal Diseases (Q36848447) (← links)
- The role of fatty acids in the development and progression of nonalcoholic fatty liver disease (Q36905995) (← links)
- The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease (Q36954679) (← links)
- Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States (Q37007941) (← links)
- Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet (Q37082262) (← links)
- Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network (Q37117549) (← links)
- Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia. (Q37253787) (← links)
- How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease? (Q37401637) (← links)
- The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction (Q37666898) (← links)
- Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet (Q37729289) (← links)
- Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease (Q37844020) (← links)
- The role of lifestyle changes in the management of chronic liver disease (Q37885466) (← links)
- Fructus Gardenia (Gardenia jasminoides J. Ellis) phytochemistry, pharmacology of cardiovascular, and safety with the perspective of new drugs development (Q38064967) (← links)
- Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats (Q38315855) (← links)
- Hepatic gene expression in morbidly obese women: implications for disease susceptibility (Q38510794) (← links)
- Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis (Q39053060) (← links)